The association between TP53 codon 72 and MDM2 promotor 309 polymorphism in Egyptian patients with hepatocellular carcinoma

The prevalence of BRAF gene mutations among Egyptianpatients with papillary thyroid carcinoma

Clinical biochemical markers for hepatocellular carcinoma in Egyptian patients

Codon 249 mutation in exon 7 of P53 gene in plasma DNA: May be a new early diagnostic marker of hepatocellular carcinoma

Vascular endothelial growth factor 634G/C gene polymorphism in prognosis of hepatocellular carcinoma in Egyptian patients

Association between MDM2-SNP309 polymorphism and hepatocellularcarcinoma in Egyptian patients with chronic viral hepatitis

P 53 mutations in tissue and blood in egyptian patientswith colorectal carcinoma and premalignant colonic lesions

Genetic Polymorphism of Uridine-Diphosphoglucuronosyl transferase 1A7 gene in chronic viral hepatitis and hepatocellular carcinoma in Egyptian patients

A study of risk factors of hepatocellular carcinomaamong Egyptian patients

A study of risk factors of hepatocellular carcinoma among Egyptian patients